Ganciclovir dosage and administration

Jump to navigation Jump to search
Ganciclovir
VITRASERT® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosage And Administration

Each Vitrasert Implant contains a minimum of 4.5 mg of ganciclovir, and is designed to release the drug over a 5 to 8 month period of time. Following depletion of ganciclovir from the Vitrasert Implant, as evidenced by progression of retinitis, the Vitrasert Implant may be removed and replaced.[1]


References

  1. "http://www.drugbank.ca/system/fda_labels/DB01004.pdf?1265922812" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.